Captrust Financial Advisors Trulieve Cannabis Corp. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	BUY	$11.51 - $21.2 $2,681 - $4,939	233 Added 2.1%	11,309 $130,000
Q1 2022 May 16, 2022	BUY	$17.1 - $26.71 $65,236 - $101,898	3,815 Added 52.54%	11,076 $233,000
Q4 2021 Feb 14, 2022	BUY	$23.38 - $30.96 $134,809 - $178,515	5,766 Added 385.69%	7,261 $189,000
Q3 2021 Nov 16, 2021	BUY	$24.13 - $38.95 $241 - $389	10 Added 0.67%	1,495 $40,000
Q2 2021 Aug 16, 2021	BUY	$35.43 - $45.24 $27,812 - $35,513	785 Added 112.14%	1,485 $56,000
Q1 2021 May 17, 2021	BUY	$33.42 - $52.78 $23,394 - $36,946	700 New	700 $32,000

61.7K

Ticker TCNNF
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,830,000
Market Cap $722M
Description
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule,...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.